
## **Trustees’ Annual Report for the period** 

**From 01/01/2025   To** 

## **31/12/2025** 

**Charity name:** A Rare Cause **Charity registration number:** 1198461 

## **Objectives and Activities** 

||SORP reference||
|---|---|---|
|Summary of the purposes of<br>the charity as set out in its<br>governing document|Para 1.17|The advancement of health or the saving of<br>lives in relation to the global rare disease<br>community, in particular by providing<br>information and resources to raise knowledge<br>and increase awareness (as set out in the<br>charity'sgoverningdocument).|
|Summary of the main<br>activities in relation to those<br>purposes for the public<br>benefit, in particular, the<br>activities, projects or<br>services identified in the<br>accounts.|Para 1.17 and<br>1.19|During the period the charity supported<br>diagnostic and clinical service delivery for rare<br>disease patients in South Africa under a service<br>level agreement with Rare Diseases South<br>Africa; received and began administering a<br>major grant from Direct Relief for the LSD-<br>Impact programme; and undertook advocacy,<br>education and awareness-raising activity,<br>including participation in international rare<br>disease conferences and working groups and<br>patient storytellingcontent.|
|Statement confirming<br>whether the trustees have<br>had regard to the guidance<br>issued by the Charity<br>Commission on public<br>benefit|Para 1.18|The trustees confirm that they have had regard<br>to the Charity Commission's general guidance<br>on public benefit in exercising their powers and<br>duties, and are satisfied that the charity's aims<br>and activities deliver public benefit consistent<br>with its objects.|



**Additional information (optional)** You may choose to include further statements where relevant about: 

||SORP reference||
|---|---|---|
|Policy on grant making|Para 1.38|Grants and programme funding are made to<br>partner organisations delivering rare disease<br>diagnostic and support services overseas,<br>under written service level agreements, with<br>outcomes reported back to the trustees.|
|Policy on social investment<br>including program related<br>investment|Para 1.38|Not applicable – the charity does not hold<br>funds for social investment.|





|Contribution made by<br>volunteers|Para 1.38|Two volunteers supported the charity's<br>activities during the period, in addition to the<br>trustees.|
|---|---|---|
|Other|||



## **Achievements and Performance** 


**----- Start of picture text -----**<br>
SORP reference<br>**----- End of picture text -----**<br>


|**Achievements and Performance**|**Achievements and Performance**|**Achievements and Performance**|
|---|---|---|
|SORP reference|||
|Summary of the main<br>achievements of the charity,<br>identifying the difference the<br>charity’s work has made to<br>the circumstances of its<br>beneficiaries and any wider<br>benefits to society as a<br>whole.|Para 1.20|The charity secured and began administering a<br>significant grant from Direct Relief in support<br>of its Lysosomal Storage Disease (LSD)-Impact<br>rare disease programme, and continued to<br>fund diagnostic support delivered in South<br>Africa through its partner, Rare Diseases South<br>Africa. Trustees and representatives<br>strengthened ARC's international standing<br>through participation in the International Rare<br>Diseases Consortium Assembly (IRDiRC), the<br>International Working Group on Gaucher<br>Disease and the International MPS Society<br>meeting, and through webinars with Rare<br>Disease International, the African Society for<br>Laboratory Medicine and other partners. Work<br>also began on a flagship African-focused<br>Gaucher disease/iPSC research initiative, and<br>the charity's public advocacy and patient-<br>storytelling activity (including a documentary<br>on MPS I) extended its reach as a credible voice<br>on rare disease andglobal health equity.|



## **Additional information (optional)** You may choose to include further statements where relevant about: 

|Achievements against<br>objectives set|Para 1.41|Diagnostic support in South Africa continued<br>under the service level agreement with Rare<br>Diseases South Africa, and the charity began<br>work on developing the first African-derived<br>iPSC models for Gaucher disease research, in<br>collaboration with academic partners in the<br>USA.|
|---|---|---|
|Performance of fundraising<br>activities against objectives<br>set|Para 1.41|The charity received a major grant from Direct<br>Relief for the LSD-Impact programme and<br>initiated a grant application to the Michael J.<br>Fox Foundation to fund a two-year<br>postdoctoral research role supporting the<br>Gaucher/iPSC initiative.|
|Investment performance<br>against objectives|Para 1.41|Not applicable – the charity does not hold an<br>investment portfolio; funds are held as cash.|





## **Financial Review** 


**----- Start of picture text -----**<br>
Review of the charity’s  Para 1.21  Total income for the period was £25,372 (2024:<br>financial position at the end  £120), principally a grant of £25,342 from<br>of the period  Direct Relief together with £30 of donations.<br>Total spending was £2,007, including £552<br>spent on the charity's programme in South<br>Africa (of which £502 was paid as a grant to<br>Rare Diseases South Africa) and the balance on<br>administration, travel and banking costs. The<br>charity held cash funds of £23,485.49 at 31<br>December 2025 (2024: £120), all as<br>unrestricted funds.<br>Statement explaining the  Para 1.22  The trustees aim to hold reserves sufficient to<br>policy for holding reserves  cover the charity's core running costs and<br>stating why they are held  committed programme spend, noting that the<br>majority of funds held at the year end are<br>earmarked for the LSD-Impact programme.<br>Amount of reserves held  Para 1.22  Total cash held was £23,485.49 at the year end,<br>the majority of which is committed to the LSD-<br>Impact programme.<br>Reasons for holding zero  Para 1.22  Not applicable – the charity held cash reserves<br>reserves  at the year end.<br>Details of fund materially in  Para 1.24  None.<br>deficit<br>Explanation of any  Para 1.23  The trustees have no material uncertainties<br>uncertainties about the  about the charity's ability to continue as a<br>charity continuing as a going  going concern.<br>concern<br>**----- End of picture text -----**<br>


|**Additional information (optional)**<br>You may choose to include further statements|**Additional information (optional)**<br>You may choose to include further statements|where relevant about:|
|---|---|---|
|The charity’s principal<br>sources of funds (including<br>any fundraising)|Para 1.47|The charity's funds are principally derived from<br>grants from international foundations and<br>NGOs (including Direct Relief) and from<br>individual donations.|
|Investment policy and<br>objectives including any<br>social investment policy<br>adopted|Para 1.46|The charity does not hold an investment<br>portfolio. Funds not immediately required are<br>held as cash with Wise Payments Ltd and, from<br>2026, CAF Bank.|
|A description of the principal<br>risks facing the charity|Para 1.46|The principal risks identified by the trustees<br>are: reliance on a small number of grant<br>funders and the risk of funding not being<br>renewed; foreign exchange and payment-<br>transfer risk on funds sent to support overseas<br>programmes; and the capacity of a small,<br>wholly volunteer trustee board to manage<br>growth in the charity's activities.|





## **Structure, Governance and Management** 

|Description of charity’s<br>trusts:|||
|---|---|---|
|Type of governing document<br>(trust deed, royal charter)|Para 1.25|Constitution (Charitable Incorporated<br>Organisation – Foundation model), registered<br>with the Charity Commission on 31 March<br>2022.|
|How is the charity<br>constituted?<br>(e.g unincorporated<br>association, CIO)|Para 1.25|A Rare Cause is constituted as a Charitable<br>Incorporated Organisation (CIO) – Foundation<br>model.|
|Trustee selection methods<br>including details of any<br>constitutional provisions e.g.<br>election to post or name of<br>any person or body entitled<br>to appoint one or more<br>trustees|Para 1.25|Trustees are appointed by the existing trustees<br>in accordance with the charity's constitution.|



**Additional information (optional)** You may choose to include further statements where relevant about: 

|Policies and procedures<br>adopted for the induction<br>and training of trustees|Para 1.51|During the year, the trustees developed,<br>reviewed and formally adopted policies<br>covering bullying and harassment,<br>international financial controls, risk<br>management, and safeguarding. These policies<br>are intended to support appropriate<br>governance, oversight, and protection of the<br>charity, its beneficiaries, volunteers, and other<br>stakeholders.|
|---|---|---|
|The charity’s organisational<br>structure and any wider<br>network with which the<br>charity works|Para 1.51|The charity is governed by a board of trustees<br>(four trustees during the period) and has no<br>employees; day-to-day activity is carried out by<br>trustees and volunteers.|
|Relationship with any<br>related parties|Para 1.51|No related party transactions were identified<br>during the period; grant recipients were not<br>related parties to the charity.|



## **Reference and Administrative details** 


**----- Start of picture text -----**<br>
Charity name  A Rare Cause<br>Other name the charity uses  ARC<br>Registered charity number  1198461<br>Charity’s principal address  6 The Green, Ilkley, LS29 7FF<br>**----- End of picture text -----**<br>




**Names of the charity trustees who manage the charity** 


**----- Start of picture text -----**<br>
Nam<br>e of<br>pers<br>on<br>(or<br>body<br>Dates acted if not for whole  )<br>Trustee name  Office (if any)<br>year  entitl<br>ed to<br>appo<br>int<br>trust<br>ee (if<br>any)<br>1 Prof Amaka Offiah Whole year<br>2 Dr Dumebi Oderinde Whole year<br>3 Tiffany Wong Whole year<br>4 Linda Ebosie From 18 June 2025<br>5<br>6<br>7<br>8<br>9<br>10<br>11<br>12<br>13<br>14<br>15<br>16<br>17<br>18<br>19<br>20<br>**----- End of picture text -----**<br>


– Corporate trustees names of the directors at the date the report was approved **Director name** Not applicable – A Rare Cause is a Charitable Incorporated Organisation and does not have corporate trustees. 



Name of trustees holding title to property belonging to the charity 


**----- Start of picture text -----**<br>
Trustee name Dates acted if not for whole year<br>Not applicable – no assets are<br>held in the names of individual<br>trustees.<br>**----- End of picture text -----**<br>


## **Funds held as custodian trustees on behalf of others** 

|Description of the assets<br>held in this capacity|Not applicable – the charity does not act as custodian trustee<br>for other charities.|
|---|---|
|Name and objects of the<br>charity on whose behalf the<br>assets are held and how this<br>falls within the custodian<br>charity’s objects||
|Details of arrangements for<br>safe custody and<br>segregation of such assets<br>from the charity’s own<br>assets||



## **Additional information (optional)** 

## **Names and addresses of advisers (Optional information)** 


**----- Start of picture text -----**<br>
Type of  Name  Address<br>adviser<br>Bankers Wise Payments Ltd 1st Floor, Worship Square, 65 Clifton Street, London EC2A 4JE<br>Bankers CAF Bank Ltd (account opened 2026, after this reporting period)<br>Name of chief executive or names of senior staff members (Optional information)<br>None – the charity has no employees; activities are undertaken by trustees and volunteers.<br>**----- End of picture text -----**<br>


## **Exemptions from disclosure** 

## Reason for non-disclosure of key personnel details 

Not applicable – no exemption from disclosure has been applied. 



**Other optional information** 

Further detail on the charity's activities and strategic priorities during the period is set out in the Trustees' Update Report (June 2026), available separately. 

## **Declarations** 

**The trustees declare that they have approved the trustees’ report above.** 

**Signed on behalf of the charity’s trustees** 


**----- Start of picture text -----**<br>
Signature(s)<br>Full name(s) Tiffany Wong<br>Position (eg  Secretary<br>Secretary, Chair, etc)<br>Date<br>October 25 2026<br>**----- End of picture text -----**<br>




## **A RARE CAUSE** 

# **Financial Statements For the year ended 31 December 2025** 

**Registered number: 1198461** 



**A RARE CAUSE CONTENTS FOR THE YEAR ENDED 31 DECEMBER 2025** 

|**CONTENTS**||
|---|---|
|**Legal and administrative information**|**Page 1**|
|**Statement of financial activities**|**Page 2**|
|**Balance sheet**|**Page 3**|





**A RARE CAUSE LEGAL AND ADMINISTRATIVE INFORMATION FOR THE YEAR ENDED 31 DECEMBER 2025** 

## **Trustees** 

- L. Ebosie 

- A. Offiah 

- D. Oderinde 

- T. Wong 

## **Charity Registered Number - 1198461** 

## **Registered Office** 

6 The Green Burley In Wharfedale Ilkley West Yorkshire LS29 7FF 

## **Accountants** 

Bloomfield’s Bloomfield Court 76 Factory Street West Atherton, Manchester M46 0EF 

1 



## **A RARE CAUSE STATEMENT OF FINANCIAL ACTIVITIES AND BALANCE SHEET FOR THE YEAR ENDED 31 DECEMBER 2025** 

|**Restricted**<br>**funds**<br>**Unrestricted**<br>**funds**<br>**2025**<br>**2025**<br>**£**<br>**£**<br>**INCOMING RESOURCES**<br>Grants received<br>**25,342**<br>**-**<br>Transfers from/to Deferred Income<br>**(22,965)**<br> **-**<br><br>**2,377**<br>**-**<br>Fundraising<br>**-**<br>**-**<br>Donations<br>**30**<br> **-**<br>**TOTAL INCOMING RESOURCES**<br>**2,407**<br> **-**<br>**RESOURCES EXPENDED**<br>**Direct Charitable Expenditure**<br>Travel<br>**1,499**<br>**-**<br>Bank Charges<br>**6**<br>**-**<br>Grants Made<br>**502**<br>**-**<br>Accountancy & Secretarial<br>**400**<br> **-**<br>**TOTAL RESOURCES EXPENDED**<br>**2,407**<br> **-**<br>**NET INCOMING / (OUTGOING)**<br>**RESOURCES BEFORE TAXATION**<br> **-**<br> **-**<br>**Taxation**<br>**-**<br>**-**<br>**NET MOVEMENT IN FUNDS**<br> **-**<br> **-**<br>Fund balances at 1 April 2024<br>**120**<br> **-**<br>**FUND BALANCES AT 31 March**<br>**2025**<br>**120**<br>**-**|**Total**<br>**funds**<br>**2025**<br>**£**<br>**25,342**<br>**(22,965)**<br>**2,377**<br>**-**<br>**30**<br>**2,407**<br>**1,499**<br>**6**<br>**502**<br>**400**<br>**2,407**<br> **-**<br> **-**<br> **-**<br>**120**<br>**120**|_Total_<br>_funds_<br>_2024_<br>_£_<br>**-**<br> **-**<br>**-**<br>**-**<br>**120**|
|---|---|---|
||<br> <br> <br>||
|||**120**|
|||**-**<br>**-**<br>**-**<br> **-**<br> **-**<br>**120**<br> **-**<br>**120**|
|||**-**|
|||**120**|



2 



## **A RARE CAUSE STATEMENT OF FINANCIAL ACTIVITIES AND BALANCE SHEET FOR THE YEAR ENDED 31 DECEMBER 2025** 

|**CURRENT ASSETS**<br>Cash and bank in hand<br>**CREDITORS**: Amounts falling due within one<br>year<br>Net current assets<br>**TOTAL ASSETS LESS CURRENT**<br>**LIABILITIES**<br>**NET ASSETS**<br>**CHARITY FUNDS**<br>Restricted funds<br>Unrestricted funds|**2025**<br>**£**<br>**23,485**<br>**23,485**<br>**(23,365)**<br>**120**<br>**120**||2024<br>**£**<br>£<br>120<br>120<br> -<br>**120**<br>120<br>120<br>**120**<br> **-**<br>**120**|£<br>120<br>120<br> - <br>120|
|---|---|---|---|---|
||||||
||||||



The directors and trustees consider that the company is entitled to exemption from the requirement to have an audit under the provisions of S.480 of the Companies Act 2006. 

No notice from the members under S.476 of the Companies Act 2006 requiring the company to have an audit has been deposited with the company. 

The directors and trustees acknowledge their responsibility for ensuring that the company keeps accounting records which comply with S.386 of the Companies Act 2006, and for preparing accounts, which give a true and fair view of the state of the affairs of the company at 31[st ] December 2025 and of its net expenditure for the year then ended in accordance with the requirements of S.396, but which otherwise comply with the requirements of the Act relating to the accounts so far as applicable to the company. 

The financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006. 

These financial statements were approved by the Trustees on                        2026 and signed on their behalf, by: October 25, 

Director 

Date______________________________2026 October 25, 

3 




6 The Green Ilkley LS29 7FF United Kingdom Registered charity in England & Wales Registration: 1198461 

Charity commission 

We believe independent auditors report is not required due to income level but audited accounts are attached and signed by trustee representative. 

KR 

Christian Hendriksz (Prof) Chief Community Impact Officer 


